IL7R and arthritic joint disease: Treatment of WT mice with anti-IL-7R (25 ± 5.9, p = 0.008; Mean area under curve ± SEM) or TSLPR-/- mice treated with PBS (24.1 ± 6.0, p = 0.019) significantly reduced clinical arthritis score compared to PBS treated WT mice (50.7 ± 6.8).